Skip to main content
. 2020 Sep 11;53:e20190454. doi: 10.1590/0037-8682-0454-2019

TABLE 4: Details of Thalidomide usage.

Thalidomide Number
Severity mentioned
ENL 35(83)
Severe ENL 7(17)
Duration of treatment
Not mentioned 15(35.71)
< 3 Months (treatment stopped) 6(14.29)
-3 months 17(40.48)
> 3 months 3(7.14)
Thalidomide and steroids indications
No neuritis 21(51)
Neuritis- Thalidomide + steroids 16(39)
Neuritis- Thalidomide alone 4(9.75)
Thalidomide dose
Not mentioned 15(36.58)
100MG 3(7.32)
150MG 1(2.44)
200MG 2(4.88)
300MG 18(43.90)
400MG 2(4.88)
Outcome
Responded 24(59)
Stopped 17(41)
Reasons for stopping Thalidomide
NR-other drugs used 8(47)
Peripheral neuropathy 2(12)
DVT 4(23)
Pregnancy 1(6)
Intolerance 1(6)
Died 1(6)